Abstract |
This study evaluated the efficacy and safety of a 3-day course of artesunate (4 mg/kg/day) for asymptomatic Plasmodium malariae infections. The parasitological cure rates on days 7 and 56 in the group treated with artesunate were 100% and 83%, respectively, compared with no cure in the placebo group (P < 0.0001).
|
Authors | Steffen Borrmann, Nicole Szlezák, Ronald K Binder, Michel A Missinou, Bertrand Lell, Peter G Kremsner |
Journal | The Journal of antimicrobial chemotherapy
(J Antimicrob Chemother)
Vol. 50
Issue 5
Pg. 751-4
(Nov 2002)
ISSN: 0305-7453 [Print] England |
PMID | 12407136
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Artemisinins
- Sesquiterpenes
- Artesunate
|
Topics |
- Adolescent
- Animals
- Artemisinins
(pharmacology, therapeutic use)
- Artesunate
- Child
- Double-Blind Method
- Female
- Humans
- Malaria
(blood, drug therapy)
- Male
- Plasmodium malariae
(drug effects)
- Sesquiterpenes
(pharmacology, therapeutic use)
|